4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001209191-24-001655
10% owner sold 4,235 shares at an average $0.85 ($3,600)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Atlas Venture Fund XI, L.P. 10% owner | 2024-01-11 | Sale | −1,566 | $0.87 | $1,362 | 2,021,836 | D |
| Atlas Venture Fund XI, L.P. 10% owner | 2024-01-11 | Sale | −569 | $0.87 | $495 | 735,373 | I |
| Atlas Venture Fund XI, L.P. 10% owner | 2024-01-12 | Sale | −1,540 | $0.83 | $1,278 | 2,020,296 | D |
| Atlas Venture Fund XI, L.P. 10% owner | 2024-01-12 | Sale | −560 | $0.83 | $465 | 734,813 | I |
| Open-market sales · 4,235 sh · avg $0.85 · $3,600 | |||||||
Loading xslF345X05/doc4.xml…